lightuponlight personal page - To The Moon

lightuponlight

lightuponlight

No personal profile

3Follow

1Followers

0Topic

0Badge

03-18

$U Power(UCAR)$ come

03-18

$HCW Biologics Inc.(HCWB)$

03-05

My Lord im in truly great need of a Miracle, goodness and greatness that you may send down to me. Amin🤲

03-03

Is this real?

Nasdaq orders Iterum Therapeutics delisting for sub-$1 bid price

02-24

$Brand Engagement Network Inc.(BNAI)$ ride

02-23

???

@700k:$Liminatus Pharma LLC(LIMN)$ Share it on premarket 2020hr SGT Congratulations to trader who bought it and sold it for day trade profit !!! When you got the right algorithm. It has 70 to 80% hit rate success on the stock with momentum using a candle stick chart. Congratulations to trader who bought it on for day trading. Don't hesitate to buy when the stock have momentum. Using chart , candle stick , uptrend line. All this is part of the strategy of success of gaining profit. So no matter what. If you going for a real trading. Plan a strategy to trade because many pro trader out there have their own strategy. Join me for daily scalp , day and swing trade on Momentum stock Follow me , Follow momentum

02-20

$Liminatus Pharma LLC(LIMN)$ come push to $3 😆🙏

02-12

$Liminatus Pharma LLC(LIMN)$ need a miracle

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4227078492909962","uuid":"4227078492909962","gmtCreate":1763974583479,"gmtModify":1770908411088,"name":"lightuponlight","pinyin":"lightuponlight","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":3,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.02.18","exceedPercentage":"93.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.01.13","exceedPercentage":"93.99%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":544000639477328,"gmtCreate":1773840386994,"gmtModify":1773840391572,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/UCAR\">$U Power(UCAR)$ </a> come","listText":"<a href=\"https://ttm.financial/S/UCAR\">$U Power(UCAR)$ </a> come","text":"$U Power(UCAR)$ come","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/544000639477328","isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":543702773838328,"gmtCreate":1773767625874,"gmtModify":1773767628303,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/HCWB\">$HCW Biologics Inc.(HCWB)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/HCWB\">$HCW Biologics Inc.(HCWB)$ </a>&nbsp;","text":"$HCW Biologics Inc.(HCWB)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/543702773838328","isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":539336793101304,"gmtCreate":1772695585370,"gmtModify":1772695589686,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"My Lord im in truly great need of a Miracle, goodness and greatness that you may send down to me. Amin🤲","listText":"My Lord im in truly great need of a Miracle, goodness and greatness that you may send down to me. Amin🤲","text":"My Lord im in truly great need of a Miracle, goodness and greatness that you may send down to me. Amin🤲","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/539336793101304","isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":538703898968816,"gmtCreate":1772541067969,"gmtModify":1772541071748,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"Is this real?","listText":"Is this real?","text":"Is this real?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/538703898968816","repostId":"2616361771","repostType":2,"repost":{"id":"2616361771","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1772488874,"share":"https://ttm.financial/m/news/2616361771?lang=en_US&edition=fundamental","pubTime":"2026-03-03 06:01","market":"nz","language":"en","title":"Nasdaq orders Iterum Therapeutics delisting for sub-$1 bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2616361771","media":"Reuters","summary":"Iterum Therapeutics plc said it received a Nasdaq delisting determination for failing to meet the exchange’s $1.00 minimum bid price requirement, with trading suspension and delisting set for March 5, 2026 unless it appeals. The company also remains below Nasdaq’s $35 million minimum market value of listed securities threshold and warned it is evaluating strategic alternatives that could include a wind-down or bankruptcy, and may later seek to suspend SEC reporting obligations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commissio","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Nasdaq orders Iterum <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> delisting for sub-$1 bid price\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Iterum Therapeutics plc said it received a Nasdaq delisting determination for failing to meet the exchange’s $1.00 minimum bid price requirement, with trading suspension and delisting set for March 5, 2026 unless it appeals. The company also remains below Nasdaq’s $35 million minimum market value of listed securities threshold and warned it is evaluating strategic alternatives that could include a wind-down or bankruptcy, and may later seek to suspend SEC reporting obligations.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-085646), on March 02, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq orders Iterum Therapeutics delisting for sub-$1 bid price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq orders Iterum Therapeutics delisting for sub-$1 bid price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-03 06:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Nasdaq orders Iterum <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> delisting for sub-$1 bid price\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Iterum Therapeutics plc said it received a Nasdaq delisting determination for failing to meet the exchange’s $1.00 minimum bid price requirement, with trading suspension and delisting set for March 5, 2026 unless it appeals. The company also remains below Nasdaq’s $35 million minimum market value of listed securities threshold and warned it is evaluating strategic alternatives that could include a wind-down or bankruptcy, and may later seek to suspend SEC reporting obligations.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-085646), on March 02, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","ITRM":"Iterum Therapeutics Plc"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLC05rp:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2616361771","content_text":"Nasdaq orders Iterum Therapeutics delisting for sub-$1 bid price\n    \n\n        Iterum Therapeutics plc said it received a Nasdaq delisting determination for failing to meet the exchange’s $1.00 minimum bid price requirement, with trading suspension and delisting set for March 5, 2026 unless it appeals. The company also remains below Nasdaq’s $35 million minimum market value of listed securities threshold and warned it is evaluating strategic alternatives that could include a wind-down or bankruptcy, and may later seek to suspend SEC reporting obligations.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-085646), on March 02, 2026, and is solely responsible for the information contained therein.","news_type":1,"symbols_score_info":{"ITRM":0.9}},"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":536264572638472,"gmtCreate":1771945674825,"gmtModify":1771947638137,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/BNAI\">$Brand Engagement Network Inc.(BNAI)$ </a> ride","listText":"<a href=\"https://ttm.financial/S/BNAI\">$Brand Engagement Network Inc.(BNAI)$ </a> ride","text":"$Brand Engagement Network Inc.(BNAI)$ ride","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/536264572638472","isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":535775478129464,"gmtCreate":1771826121506,"gmtModify":1771826712073,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/535775478129464","repostId":"528972000646712","repostType":1,"repost":{"id":528972000646712,"gmtCreate":1770165634390,"gmtModify":1770169430748,"author":{"id":"3561775119462661","authorId":"3561775119462661","name":"700k","avatar":"https://community-static.tradeup.com/news/c822cf27b8c85ca6e6d8dd110dc73ab1","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3561775119462661","idStr":"3561775119462661"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a>&nbsp; Share it on premarket 2020hr SGT Congratulations to trader who bought it and sold it for day trade profit !!! When you got the right algorithm. It has 70 to 80% hit rate success on the stock with momentum using a candle stick chart. Congratulations to trader who bought it on for day trading. Don't hesitate to buy when the stock have momentum. Using chart , candle stick , uptrend line. All this is part of the strategy of success of gaining profit. So no matter what. If you going for a real trading. Plan a strategy to trade because many pro trader out there have their own strategy. Join me for daily scalp , day and swing trade on Momentum stock Follow me , Follow momentum&nbsp;","listText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a>&nbsp; Share it on premarket 2020hr SGT Congratulations to trader who bought it and sold it for day trade profit !!! When you got the right algorithm. It has 70 to 80% hit rate success on the stock with momentum using a candle stick chart. Congratulations to trader who bought it on for day trading. Don't hesitate to buy when the stock have momentum. Using chart , candle stick , uptrend line. All this is part of the strategy of success of gaining profit. So no matter what. If you going for a real trading. Plan a strategy to trade because many pro trader out there have their own strategy. Join me for daily scalp , day and swing trade on Momentum stock Follow me , Follow momentum&nbsp;","text":"$Liminatus Pharma LLC(LIMN)$ Share it on premarket 2020hr SGT Congratulations to trader who bought it and sold it for day trade profit !!! When you got the right algorithm. It has 70 to 80% hit rate success on the stock with momentum using a candle stick chart. Congratulations to trader who bought it on for day trading. Don't hesitate to buy when the stock have momentum. Using chart , candle stick , uptrend line. All this is part of the strategy of success of gaining profit. So no matter what. If you going for a real trading. Plan a strategy to trade because many pro trader out there have their own strategy. Join me for daily scalp , day and swing trade on Momentum stock Follow me , Follow momentum","images":[{"img":"https://community-static.tradeup.com/news/7d28e3267f23e2d6e36d385a2c38255a","width":"3046","height":"4096"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/528972000646712","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":534509738570088,"gmtCreate":1771517093521,"gmtModify":1771545731677,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a> come push to $3 😆🙏","listText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a> come push to $3 😆🙏","text":"$Liminatus Pharma LLC(LIMN)$ come push to $3 😆🙏","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/534509738570088","isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":532007115265480,"gmtCreate":1770906267164,"gmtModify":1770908484067,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a> need a miracle","listText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a> need a miracle","text":"$Liminatus Pharma LLC(LIMN)$ need a miracle","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/532007115265480","isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":539336793101304,"gmtCreate":1772695585370,"gmtModify":1772695589686,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"My Lord im in truly great need of a Miracle, goodness and greatness that you may send down to me. Amin🤲","listText":"My Lord im in truly great need of a Miracle, goodness and greatness that you may send down to me. Amin🤲","text":"My Lord im in truly great need of a Miracle, goodness and greatness that you may send down to me. Amin🤲","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/539336793101304","isVote":1,"tweetType":1,"viewCount":243,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":544000639477328,"gmtCreate":1773840386994,"gmtModify":1773840391572,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/UCAR\">$U Power(UCAR)$ </a> come","listText":"<a href=\"https://ttm.financial/S/UCAR\">$U Power(UCAR)$ </a> come","text":"$U Power(UCAR)$ come","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/544000639477328","isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":543702773838328,"gmtCreate":1773767625874,"gmtModify":1773767628303,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/HCWB\">$HCW Biologics Inc.(HCWB)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/HCWB\">$HCW Biologics Inc.(HCWB)$ </a>&nbsp;","text":"$HCW Biologics Inc.(HCWB)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/543702773838328","isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":538703898968816,"gmtCreate":1772541067969,"gmtModify":1772541071748,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"Is this real?","listText":"Is this real?","text":"Is this real?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/538703898968816","repostId":"2616361771","repostType":2,"repost":{"id":"2616361771","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1772488874,"share":"https://ttm.financial/m/news/2616361771?lang=en_US&edition=fundamental","pubTime":"2026-03-03 06:01","market":"nz","language":"en","title":"Nasdaq orders Iterum Therapeutics delisting for sub-$1 bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2616361771","media":"Reuters","summary":"Iterum Therapeutics plc said it received a Nasdaq delisting determination for failing to meet the exchange’s $1.00 minimum bid price requirement, with trading suspension and delisting set for March 5, 2026 unless it appeals. The company also remains below Nasdaq’s $35 million minimum market value of listed securities threshold and warned it is evaluating strategic alternatives that could include a wind-down or bankruptcy, and may later seek to suspend SEC reporting obligations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commissio","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Nasdaq orders Iterum <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> delisting for sub-$1 bid price\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Iterum Therapeutics plc said it received a Nasdaq delisting determination for failing to meet the exchange’s $1.00 minimum bid price requirement, with trading suspension and delisting set for March 5, 2026 unless it appeals. The company also remains below Nasdaq’s $35 million minimum market value of listed securities threshold and warned it is evaluating strategic alternatives that could include a wind-down or bankruptcy, and may later seek to suspend SEC reporting obligations.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-085646), on March 02, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq orders Iterum Therapeutics delisting for sub-$1 bid price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq orders Iterum Therapeutics delisting for sub-$1 bid price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-03 06:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Nasdaq orders Iterum <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> delisting for sub-$1 bid price\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Iterum Therapeutics plc said it received a Nasdaq delisting determination for failing to meet the exchange’s $1.00 minimum bid price requirement, with trading suspension and delisting set for March 5, 2026 unless it appeals. The company also remains below Nasdaq’s $35 million minimum market value of listed securities threshold and warned it is evaluating strategic alternatives that could include a wind-down or bankruptcy, and may later seek to suspend SEC reporting obligations.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-085646), on March 02, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","ITRM":"Iterum Therapeutics Plc"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLC05rp:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2616361771","content_text":"Nasdaq orders Iterum Therapeutics delisting for sub-$1 bid price\n    \n\n        Iterum Therapeutics plc said it received a Nasdaq delisting determination for failing to meet the exchange’s $1.00 minimum bid price requirement, with trading suspension and delisting set for March 5, 2026 unless it appeals. The company also remains below Nasdaq’s $35 million minimum market value of listed securities threshold and warned it is evaluating strategic alternatives that could include a wind-down or bankruptcy, and may later seek to suspend SEC reporting obligations.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iterum Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-085646), on March 02, 2026, and is solely responsible for the information contained therein.","news_type":1,"symbols_score_info":{"ITRM":0.9}},"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":536264572638472,"gmtCreate":1771945674825,"gmtModify":1771947638137,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/BNAI\">$Brand Engagement Network Inc.(BNAI)$ </a> ride","listText":"<a href=\"https://ttm.financial/S/BNAI\">$Brand Engagement Network Inc.(BNAI)$ </a> ride","text":"$Brand Engagement Network Inc.(BNAI)$ ride","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/536264572638472","isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":535775478129464,"gmtCreate":1771826121506,"gmtModify":1771826712073,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/535775478129464","repostId":"528972000646712","repostType":1,"repost":{"id":528972000646712,"gmtCreate":1770165634390,"gmtModify":1770169430748,"author":{"id":"3561775119462661","authorId":"3561775119462661","name":"700k","avatar":"https://community-static.tradeup.com/news/c822cf27b8c85ca6e6d8dd110dc73ab1","crmLevel":4,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3561775119462661","idStr":"3561775119462661"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a>&nbsp; Share it on premarket 2020hr SGT Congratulations to trader who bought it and sold it for day trade profit !!! When you got the right algorithm. It has 70 to 80% hit rate success on the stock with momentum using a candle stick chart. Congratulations to trader who bought it on for day trading. Don't hesitate to buy when the stock have momentum. Using chart , candle stick , uptrend line. All this is part of the strategy of success of gaining profit. So no matter what. If you going for a real trading. Plan a strategy to trade because many pro trader out there have their own strategy. Join me for daily scalp , day and swing trade on Momentum stock Follow me , Follow momentum&nbsp;","listText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a>&nbsp; Share it on premarket 2020hr SGT Congratulations to trader who bought it and sold it for day trade profit !!! When you got the right algorithm. It has 70 to 80% hit rate success on the stock with momentum using a candle stick chart. Congratulations to trader who bought it on for day trading. Don't hesitate to buy when the stock have momentum. Using chart , candle stick , uptrend line. All this is part of the strategy of success of gaining profit. So no matter what. If you going for a real trading. Plan a strategy to trade because many pro trader out there have their own strategy. Join me for daily scalp , day and swing trade on Momentum stock Follow me , Follow momentum&nbsp;","text":"$Liminatus Pharma LLC(LIMN)$ Share it on premarket 2020hr SGT Congratulations to trader who bought it and sold it for day trade profit !!! When you got the right algorithm. It has 70 to 80% hit rate success on the stock with momentum using a candle stick chart. Congratulations to trader who bought it on for day trading. Don't hesitate to buy when the stock have momentum. Using chart , candle stick , uptrend line. All this is part of the strategy of success of gaining profit. So no matter what. If you going for a real trading. Plan a strategy to trade because many pro trader out there have their own strategy. Join me for daily scalp , day and swing trade on Momentum stock Follow me , Follow momentum","images":[{"img":"https://community-static.tradeup.com/news/7d28e3267f23e2d6e36d385a2c38255a","width":"3046","height":"4096"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/528972000646712","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":534509738570088,"gmtCreate":1771517093521,"gmtModify":1771545731677,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a> come push to $3 😆🙏","listText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a> come push to $3 😆🙏","text":"$Liminatus Pharma LLC(LIMN)$ come push to $3 😆🙏","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/534509738570088","isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":532007115265480,"gmtCreate":1770906267164,"gmtModify":1770908484067,"author":{"id":"4227078492909962","authorId":"4227078492909962","name":"lightuponlight","avatar":"https://community-static.tradeup.com/news/95acdbc1b1293207cce2403f818ddf76","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4227078492909962","idStr":"4227078492909962"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a> need a miracle","listText":"<a href=\"https://ttm.financial/S/LIMN\">$Liminatus Pharma LLC(LIMN)$ </a> need a miracle","text":"$Liminatus Pharma LLC(LIMN)$ need a miracle","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/532007115265480","isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}